Low Cost, Highly Accurate, Simple to Use
Testing for All
Domus Diagnostics is working to combine cutting-edge custom chemistry with simple manufacturing technology in order to bring low-cost, high accuracy tests for infectious diseases everywhere they're needed.
Domus technology has disruptive potential across the continuum of care.
Proprietary* RT-LAMP one-step, one-temperature technology allows for high performance, low-cost solutions everywhere you find diagnostic tests
Domus tests will be among the first to meet the standards required for broad adoption in every global market.
Low Cost
Novel chemistry and simple manufacturing allow for ultra low-cost solutions for at-home, point-of-care, and central laboratory testing
Simple
Intuitive and easy to use, across languages,
education levels, and disabilities
Accurate
As accurate as a
laboratory PCR test:
>95% sensitivity and
100% specificity*
Rapid
Results in 30 minutes or less
The National Institutes of Health (NIH) Rapid Acceleration of Diagnostics (RADx®) Tech program awards Domus a multi-million dollar grant.
The RADx Coordination Center at CIMIT, on behalf of the National Institute of Biomedical Imaging and Bioengineering (NIBIB) of the National Institutes of Health (NIH), selected Domus Diagnostics earlier this year from among hundreds of applicants to participate in their High-Performance COVID-19 Rapid Tests Fast-Track Program, to accelerate the development of their ultra-low-cost nucleic acid at-home test.